Clinical evaluation of seven anticalculus dentifrice formulations.
One hundred ninety-two subjects completed a clinical trial to determine the effects of seven dentifrice formulations on calculus inhibition. The double-blind study involved a ten-day control phase and a ten-day experimental phase. For the control phase, subjects were evaluated for calculus present, received a prophylaxis and had pre-weighed mylar strips attached to the lingual surfaces of the mandibular incisors to harvest mineral deposits. Subjects were then assigned the placebo dentifrice for unsupervised twice-daily use and were required to report once a day for a supervised mouthrinse using a 1:3 dilution of the dentrifice. The experimental phase was identical except that subjects were allocated the experimental dentifices using a stratified random assignment based on age, gender and the initial presence of calculus. Simple linear regression analyses of the dry and ash log weights obtained from the strips were performed. The results showed no statistically significant differences among the test products; however, two formulations containing zinc citrate showed some calculus inhibition-potential suggesting that further research and development of such products may be warranted.
Scruggs
R R
RR
University of North Carolina Dental Research Center.
Stewart
P W
PW
Samuels
M S
MS
Stamm
J W
JW
D000328:Adult; D002951:Citrates / Q000627:therapeutic use*; D019343:Citric Acid; D003728:Dental Calculus / Q000517:prevention & control*; D003802:Dentifrices; D011756:Diphosphates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008298:Maleates; D008875:Middle Aged; D011145:Polyvinyls
D002951:Citrates; D003802:Dentifrices; D011756:Diphosphates; D008298:Maleates; D011145:Polyvinyls; C058026:polyvinylmethoxyethylene-maleic anhydride copolymer; D019343:Citric Acid